These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31253644)

  • 1. Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1.
    Deuss FA; Watson GM; Goodall KJ; Leece I; Chatterjee S; Fu Z; Thaysen-Andersen M; Andrews DM; Rossjohn J; Berry R
    J Biol Chem; 2019 Aug; 294(33):12534-12546. PubMed ID: 31253644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5.
    Wang H; Qi J; Zhang S; Li Y; Tan S; Gao GF
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):988-996. PubMed ID: 30591568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis for CD96 Immune Receptor Recognition of Nectin-like Protein-5, CD155.
    Deuss FA; Watson GM; Fu Z; Rossjohn J; Berry R
    Structure; 2019 Feb; 27(2):219-228.e3. PubMed ID: 30528596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226.
    Liu J; Qian X; Chen Z; Xu X; Gao F; Zhang S; Zhang R; Qi J; Gao GF; Yan J
    J Immunol; 2012 Jun; 188(11):5511-20. PubMed ID: 22547693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy.
    Wu B; Zhong C; Lang Q; Liang Z; Zhang Y; Zhao X; Yu Y; Zhang H; Xu F; Tian Y
    J Exp Clin Cancer Res; 2021 Aug; 40(1):267. PubMed ID: 34433460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of CD155 glycosylation in functional binding to DNAM-1 on natural killer cells.
    Tahara S; Okumura G; Matsuo T; Shibuya A; Shibuya K
    Int Immunol; 2024 Apr; 36(6):317-325. PubMed ID: 38289706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.
    de Andrade LF; Smyth MJ; Martinet L
    Immunol Cell Biol; 2014 Mar; 92(3):237-44. PubMed ID: 24343663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
    Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A
    J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
    Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
    Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).
    Deuss FA; Gully BS; Rossjohn J; Berry R
    J Biol Chem; 2017 Jul; 292(27):11413-11422. PubMed ID: 28515320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.
    Shibuya A; Shibuya K
    Int Immunol; 2021 Nov; 33(12):687-692. PubMed ID: 34694361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
    Sanchez-Correa B; Valhondo I; Hassouneh F; Lopez-Sejas N; Pera A; Bergua JM; Arcos MJ; Bañas H; Casas-Avilés I; Durán E; Alonso C; Solana R; Tarazona R
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
    Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
    Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between nectin-1 and the human natural killer cell receptor CD96.
    Holmes VM; Maluquer de Motes C; Richards PT; Roldan J; Bhargava AK; Orange JS; Krummenacher C
    PLoS One; 2019; 14(2):e0212443. PubMed ID: 30759143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands.
    Tahara-Hanaoka S; Miyamoto A; Hara A; Honda S; Shibuya K; Shibuya A
    Biochem Biophys Res Commun; 2005 Apr; 329(3):996-1000. PubMed ID: 15752754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
    Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
    Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD155 mutation (Ala67Thr) increases the binding affinity for and the signaling via an inhibitory immunoreceptor TIGIT.
    Matsuo T; Iguchi-Manaka A; Shibuya A; Shibuya K
    Cancer Sci; 2022 Nov; 113(11):4001-4004. PubMed ID: 35947095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNAM-1 controls NK cell activation via an ITT-like motif.
    Zhang Z; Wu N; Lu Y; Davidson D; Colonna M; Veillette A
    J Exp Med; 2015 Nov; 212(12):2165-82. PubMed ID: 26552706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.
    Ardolino M; Zingoni A; Cerboni C; Cecere F; Soriani A; Iannitto ML; Santoni A
    Blood; 2011 May; 117(18):4778-86. PubMed ID: 21406724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.
    Chan CJ; Martinet L; Gilfillan S; Souza-Fonseca-Guimaraes F; Chow MT; Town L; Ritchie DS; Colonna M; Andrews DM; Smyth MJ
    Nat Immunol; 2014 May; 15(5):431-8. PubMed ID: 24658051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.